Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer

Launched by NANJING MEDICAL UNIVERSITY · Aug 6, 2019

Keywords

ClinConnect Summary

This clinical trial is looking into whether pancreatic cancer can cause a condition called heterotopic ossification, which is when bone forms in places where it shouldn't, such as in the abdominal area after surgery. Researchers want to understand how this happens, especially in patients who have had surgery for pancreatic cancer. The study is not yet recruiting participants, but when it begins, it will focus on people aged 65 to 74 years.

To be eligible for this trial, participants must provide consent and have had a specific type of abdominal surgery where the incision was closed in a particular way. However, individuals who have a history of other cancers, previous surgeries in the mid-abdomen, or certain metabolic conditions affecting calcium and phosphorus will not be able to join. Participants can expect to contribute to important research that may help improve understanding and treatment of complications related to pancreatic cancer surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Obtain informed consent from the patients.
• • The patient's abdominal incision was double-closed with continuous suture of linea alba and fascia with absorbable suture, and skin was sutured with skin staples.
• Exclusion Criteria:
• • Refusing to join the study
• • Previous history of malignant tumor
• • Previous history of midabdominal incision
• • Abnormal calcium and phosphorus metabolism
• • Distant metastasis
• • Palliative operation
• • performing neoadjuvant chemotherapy